Straumann XenoFlex - Dental bone matrix implant, animal-derived

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Available from:

Emergo Asia Pacific Pty Ltd T/a Emergo Australia

Class:

Class III

Manufactured by:

Nibec Co Ltd 116 Bamdi-gil lwol-myeon Jincheon-gun, Chungcheongbuk-do, 27816 Korea - Republic of

Therapeutic area:

47968 - Dental bone matrix implant, animal-derived

Therapeutic indications:

Straumann XenoFlex is a combination of purified cancellous bovine bone mineral granules (Straumann Xenograft) and 10 percent porcine collagen in block form in a blister pack, or in a cylindrical form in a syringe and a blister pack. It is sterilized by gamma irradiation. Straumann XenoFlex is recommended for: - Augmentation or reconstructive treatment of the alveolar ridge. - Filling of infrabony periodontal defects. - Filling of defects after root resection, apicoectomy, and cystectomy. - Filling of extraction sockets to enhance preservation of the alveolar ridge. - Elevation of the maxillary sinus floor. - Filling of periodontal defects in conjunction with products intend for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR). - Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR).

Authorization status:

A

Authorization date:

2022-03-01